Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free ONCSQ Stock Alerts

OncoSec Medical (ONCSQ) Competitors

Compare

ONCSQ vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy OncoSec Medical stock or one of its competitors? MarketBeat compares OncoSec Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OncoSec Medical include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does OncoSec Medical compare to Ainos?

Ainos (NASDAQ:AIMDW) and OncoSec Medical (NASDAQ:ONCSQ) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
OncoSec Medical N/A N/A N/A

In the previous week, Ainos had 2 more articles in the media than OncoSec Medical. MarketBeat recorded 2 mentions for Ainos and 0 mentions for OncoSec Medical. Ainos' average media sentiment score of 0.44 beat OncoSec Medical's score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Neutral
OncoSec Medical Neutral

Ainos has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Summary

Ainos beats OncoSec Medical on 3 of the 3 factors compared between the two stocks.

How does OncoSec Medical compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and OncoSec Medical (NASDAQ:ONCSQ) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
OncoSec Medical N/A N/A N/A

Alvotech has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

In the previous week, Alvotech had 2 more articles in the media than OncoSec Medical. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for OncoSec Medical. Alvotech's average media sentiment score of 1.44 beat OncoSec Medical's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
OncoSec Medical Neutral

Summary

Alvotech beats OncoSec Medical on 3 of the 3 factors compared between the two stocks.

How does OncoSec Medical compare to Aravive?

Aravive (NASDAQ:ARAV) and OncoSec Medical (NASDAQ:ONCSQ) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
OncoSec Medical N/A N/A N/A

Aravive is trading at a lower price-to-earnings ratio than OncoSec Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
OncoSec Medical Neutral

Summary

Aravive beats OncoSec Medical on 3 of the 4 factors compared between the two stocks.

How does OncoSec Medical compare to Atlantic Coastal Acquisition Corp. II?

OncoSec Medical (NASDAQ:ONCSQ) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
OncoSec Medical Neutral
Atlantic Coastal Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Summary

OncoSec Medical and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does OncoSec Medical compare to Biofrontera?

OncoSec Medical (NASDAQ:ONCSQ) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

In the previous week, Biofrontera had 2 more articles in the media than OncoSec Medical. MarketBeat recorded 2 mentions for Biofrontera and 0 mentions for OncoSec Medical. Biofrontera's average media sentiment score of 0.43 beat OncoSec Medical's score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
OncoSec Medical Neutral
Biofrontera Neutral

Biofrontera has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
Biofrontera$43.20MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Biofrontera N/A N/A N/A

Summary

Biofrontera beats OncoSec Medical on 3 of the 3 factors compared between the two stocks.

Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

Export
MetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$973.06M$55.95B$30.05B
Dividend YieldN/A4.84%2.69%5.33%
P/E Ratio0.001.4721.6326.27
Price / SalesN/A119.77565.57116.86
Price / CashN/A20.0643.2256.84
Price / BookN/A7.6810.557.30
Net Income-$34.18M-$3.80M$3.56B$337.27M

OncoSec Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$0.00N/AN/A40
AIMDW
Ainos
N/A$0.06
-13.3%		N/A-21.5%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.19
flat		N/A-88.0%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ONCSQ) was last updated on 5/31/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel